Ryoichi Tsuji

Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction

Kenro Yoshimoto, Takao Tanaka, Kohichi Somiya et al. · Heart and Vessels · 1995 · 77 citations

Metabolic Syndrome, Cardiomyopathy, Heart Failure +9

Human heart-type cytoplasmic fatty acid-binding protein in serum and urine during hyperacute myocardial infarction

Ryoichi Tsuji, Takao Tanaka, Koichi Sohmiya et al. · International Journal of Cardiology · 1993 · 66 citations

Metabolic Syndrome, Cardiomyopathy, Heart Failure +10

Plasma and Urinary Heart-Type Cytoplasmic Fatty Acid-Binding Protein in Coronary Occlusion and Reperfusion Induced Myocardial Injury Model

Koichi Sohmiya, Takao Tanaka, Ryoichi Tsuji et al. · Journal of Molecular and Cellular Cardiology · 1993 · 42 citations

Inflammation, Cardiac Muscle, Heart Failure +11

Inhibition by 8-hydroxy-2-(di-n-propylamino) tetralin and SM-3997, a novel anxiolytic drug, of the hippocampal rhythmical slow activity mediated by 5-hydroxytryptamine1A receptors

Akihiko Hirose, Ryoichi Tsuji, Hiroshi Shimizu et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1990 · 23 citations

Neurophysiology, Novel Anxiolytic Drug, Medicine +10

The effect of pravastatin on prevention of restenosis after successful percutaneous transluminal coronary angioplasty.

Haruhiko Onaka, Yuzo Hirota, Yoshio Kita et al. · Japanese Circulation Journal · 1994 · 20 citations · Full text